Seeking Alpha

MRX
Medicis Pharmaceutical Corporation

5/26/2012, 5:00 PM ET
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
MRX Market Currents more »
  • Friday 2:44 PM Medicis (MRX +1.3%) gains on positive comments out of Goldman earlier today. The firm says the company is one of the most likely M&A targets in its peer group, and notes that its growth potential is under appreciated. It reiterats a Buy rated with a $45 price target.
    Comment!
    [Healthcare, On the Move]
MRX in Focus more »
MRX Instablog posts more »
  • Magic Formula Investing Weekly Roundup 3/4/2012
    Sun, Mar 4 • MagicDiligence • Comment!
  • The Best Stocks With Dividend Growth From Last Week (February 27 - March 04, 2012)
    Sun, Mar 4 • Dividend Sheet • Comment!
  • Magic Formula Investing Weekly Roundup 1/22/2012
    Sun, Jan 22 • MagicDiligence • Comment!
  • Medicis Completes Acquisition - Previous Acquisition Sold at Huge Loss.
    Mon, Dec 5, 2011 • Disclosure Insight • Comment!
  • Magic Formula Investing Weekly Roundup 12/5/2011
    Mon, Dec 5, 2011 • MagicDiligence • Comment!
Write a post on MRX
MRX StockTalks
MRX vs. ETF Alternatives
Company Description

Medicis Pharmaceutical Corporation together with our wholly owned subsidiaries, is a leading independent specialty pharmaceutical company focusing primarily on helping patients attain a healthy and youthful appearance and self-image through the development and marketing in the United States... More

Sector: Healthcare
Industry: Biotechnology
Country: United States